Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/22/2025

Risk of Additional Diabetic Complications in Patients with Diabetic Foot

Understanding the Risk Profile

  • Peripheral neuropathy is present in 78% of patients who develop diabetic foot ulcers, making it the most common component cause 1, 2.
  • Peripheral arterial disease (PAD) coexists in up to 50% of patients with diabetic foot ulcers, representing neuro-ischemic disease rather than purely neuropathic ulcers 3.
  • Retinopathy is a recognized risk factor for diabetic foot complications, indicating parallel microvascular damage 2.
  • Nephropathy, particularly in patients on dialysis or post-transplant, significantly increases risk for foot complications and represents concurrent end-organ damage 2, 4.

The Mortality and Morbidity Burden

  • Diabetic foot ulceration is associated with high levels of morbidity and mortality 5.
  • The lifetime incidence of diabetes-related foot ulceration is 19%-34%, with yearly incidence of 2% and recurrence rates of 40% within one year after healing and 65% within three years 5.

Specific Complications to Monitor

Cardiovascular Disease

  • Poor glycemic control over years affects not only peripheral nerves but also accelerates atherosclerosis, leading to PAD in approximately half of diabetic foot patients 3.
  • The presence of PAD is an important risk factor for impaired wound healing and lower extremity amputation 3.

Renal Complications

  • Chronic kidney disease, especially requiring dialysis, represents a major risk factor that clusters with diabetic foot disease 2, 4.
  • Patients on dialysis require the most intensive foot surveillance (every 1-3 months) due to their high-risk status 2.

Visual Impairment

  • Visual impairment from diabetic retinopathy is both a risk factor for foot complications and a concurrent complication 2, 4.
  • This creates a dangerous cycle where patients cannot adequately inspect their own feet for early problems 2.

Progressive Neuropathy

  • Loss of protective sensation (LOPS) leads to insensitive and deformed feet with abnormal walking patterns 3.

Clinical Implications for Management

Intensive Surveillance Requirements

  • Patients with a history of foot ulceration or amputation require examination every 1-3 months (IWGDF Category 3) 2, 3, 4.
  • This intensive schedule reflects the high risk of both recurrent foot problems and progression of other diabetic complications 3.

Integrated Multi-Organ Assessment

  • An interprofessional approach is recommended for individuals with foot ulcers and high-risk feet, including those on dialysis, with Charcot foot, or with history of prior ulcers or amputation 2.
  • Assessment should include glycemic control, cardiovascular status, renal function, and ophthalmologic evaluation 2, 4.

Risk Stratification Guides Intensity

  • The IWGDF Risk Classification System stratifies patients from Category 0 (no neuropathy, annual screening) to Category 3 (neuropathy with history of ulcer/amputation, screening every 1-3 months) 3, 4, 6.
  • Category 3 patients represent those with the highest risk for both recurrent foot problems and concurrent diabetic complications 3.

Common Pitfalls to Avoid

  • Do not assume diabetic foot disease exists in isolation—it is a marker of systemic diabetic complications requiring comprehensive evaluation 2, 3.
  • Do not rely on symptoms alone—patients may have asymptomatic severe ischemia due to concurrent neuropathy masking pain 3.
  • Diabetic microangiopathy ("small vessel disease") is not the primary cause of ulcers or poor wound healing; focus on large vessel PAD and neuropathy 3.
  • Do not perform nerve decompression procedures as they do not prevent foot ulcers and are not recommended over standard care 1, 5, 7.

REFERENCES

4

Diabetic Foot Care Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

6

Diabetic Foot Screening and Risk Stratification [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7

Management of Foot Neuroma in Diabetic Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026